Whole-genome sequencing may optimize PARP inhibitor use for cancer patients

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...
TipRanks on MSN

Profound Medical’s TULSA-PRO marks first commercial case at Johns Hopkins

Profound Medical ( ($TSE:PRN) ) has shared an announcement. Profound Medical announced that The Johns Hopkins Hospital has performed its first ...

Biggest advancement in cancer treatment in SWFL: What is it?

The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...
Reuters

Arvinas, Pfizer to grant commercial rights of experimental breast cancer drug to third party

Sept 17 (Reuters) - Drug developer Arvinas (ARVN.O), opens new tab said on Wednesday it will grant commercialization rights of an experimental breast cancer treatment it was developing with Pfizer ...
Morningstar

MiraDx Announces the Commercial Availability of PROSTOX™ ultra for Prediction of Risk of Late Genitourinary Toxicity in Prostate Cancer Patients Considering Radiation Therapy

MiraDx Announces the Commercial Availability of PROSTOX™ ultra for Prediction of Risk of Late Genitourinary Toxicity in Prostate Cancer Patients Considering Radiation Therapy MiraDx, a molecular ...
Seeking Alpha

PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement

The Veris Cancer Care Platform to be deployed to enhance personalized cancer care in patients undergoing systemic cancer therapy across OSUCCC – James "We are pleased to move into the commercial phase ...